Chinese Society of Pediatric Endocrinology and Metabolism
Dr. Xiaoping Luo is the Professor and Chairman of the Department of Pediatrics, Tongji Hospital, Director of the Center for the Diagnosis of Genetic Metabolic Diseases, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Dr. Luo obtained his medical degree from Tongji Medical University in 1985. After graduate study, he stayed in the Department of Pediatrics of the affiliated Tongji Hospital and specialized in neonatology, and was appointed as an associate professor of pediatrics in 1992. From January 1994, he worked as a visiting scientist in the Division of Genetic Metabolic Diseases in the Department of Pediatric Laboratory Medicine in the Hospital for Sick Children in Toronto. In July 1997, he joined the CIHR group in Lung Development and Neonatal Research, and the Lung Biology Programme in the Research Institute of the Hospital for Sick Children, as a research associate/scientist. He was appointed as an adjunct professor in the Department of Paediatrics, Faculty of Medicine, University of Toronto since 2000, before he moved back to China where he subsequently became a full professor and vice chairman of the Department of Pediatrics, Tongji Hospital. He assumed his current positions as Chairman of the Department of Pediatrics in Tongji Hospital in Wuhan in 2003.
Dr. Luo is now the Vice President of the Chinese Pediatric Society (CPS), Honorary president of the Chinese Society of Pediatric Endocrinology and Metabolism (CSPEM). He is also the past president for the Asia Pacific Paediatric Endocrine Society (APPES), Executive Committee member of the Global Pediatric Endocrinology and Diabetes (GPED), Board of Directors for the Asian Society for Inherited Metabolic Diseases (ASIMD). His main interests are pediatric endocrinology and metabolism, and neonatal/perinatal medicine. Dr. Luo’s research was funded by the National Natural Science Foundation of China, the Ministry of Health, the Ministry of Education, and the Ministry of Science and Technology of China, and the World Diabetes Foundation, etc. He has published 60 book chapters and over 530 peer reviewed articles, and served as editor or reviewer for 45 domestic and international medical journals.
Prof. Jun-fen Fu, born in 1968, is the vice president of Children’s Hospital of Zhejiang University School of Medicine, Chief Physician and Director of Endocrinology Department of Children's Hospital, Zhejiang University School of Medicine.
She is a tutor of PhD, MD and professor of Zhejiang University. She is also the Zhejiang provincial New Century 151 Talent, the current secretary-general of APPES (Asia Pacific Pediatric Endocrine Society), the vice president of National Clinical Research Center for Child Health and National Children's Regional Medical Center, the president of Endocrine Genetic Metabolism Group, Pediatric Society of Chinese Medical Association, the vice president of Children's Disease and Health Society of China Maternal and Child Health Association (CMCHA).In 2001, she was awarded a Chinese National Scholarship that supported her to study at Yamagata University School of Medicine in Japan as a visiting scholar. During the year of Jul 2005 to Aug 2006, she got professional training in Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, University of Bristol, UK. In 2008, she got short term (3 months) clinical training at the University of California, Los Angeles (UCLA). She has been working in the Division of Endocrinology in this Hospital on clinical, teaching and research work as a pediatrician for more than 20 years.
Junfen Fu, as a representative of Children’s Hospital of Zhejiang University School of Medicine, signed a China-New Zealand cooperation agreement on chronic non-infectious diseases and started substantive cooperation with the University of Auckland, New Zealand. 3 research papers have been jointly published whilst her team cooperated with the McGill University Fellows team in Canada to conduct precision diagnosis research on single-gene diabetes and prepared for the establishment of the International Childhood Diabetes Precision Diagnosis and Treatment Center.